ResearcherAjou UniversityNo recent work listed

Hyun Woo Lee

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6879-9686; OpenAlex author ID A5100607088. Sources: ClinicalTrials.gov.

Their work

Papers: 4
Trials: 1 (principal investigator on 1)
Grants: 0
Labs led: 0
Collaborators: 18

Papers, trials and grants by year

2016: 1 trial · 2017: 2 papers · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper

Papers 4

Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients: A randomised controlled trial (MPACA-3). Co-author DOI 10.1016/j.ejca.2021.08.002 ↗
Attenuated FOLFIRINOX in the salvage treatment of gemcitabine-refractory advanced pancreatic cancer: a phase II study. Co-author DOI 10.1186/s40880-018-0304-1 ↗
Vascular enhancement pattern of mass in computed tomography may predict chemo-responsiveness in advanced pancreatic cancer. Co-author DOI 10.1016/j.pan.2016.10.008 ↗
Diagnostic evaluation of simulation CT images for adjuvant radiotherapy in pancreatic adenocarcinoma. Co-author DOI 10.1259/bjr.20170225 ↗

Trials 1

Study of Weekly Genexol®-PM Plus Gemcitabine in Subjects With Recurrent and Metastatic Adenocarcinoma of the Pancreas Principal investigator NCT02739633 ↗

Closest collaborators

The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jung Hun Kang · 2 shared papers, 2018–2021 · strength 0.18
- Paper Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients:… DOI 10.1016/j.ejca.2021.08.002 ↗
- Paper Attenuated FOLFIRINOX in the salvage treatment of gemcitabine-refractory advanced pancreatic cancer: a phase II study. DOI 10.1186/s40880-018-0304-1 ↗
Jung Hoon Kim · 2 shared papers, 2018–2021 · strength 0.18
- Paper Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients:… DOI 10.1016/j.ejca.2021.08.002 ↗
- Paper Attenuated FOLFIRINOX in the salvage treatment of gemcitabine-refractory advanced pancreatic cancer: a phase II study. DOI 10.1186/s40880-018-0304-1 ↗
In Gyu Hwang · 2 shared papers, 2018–2021 · strength 0.18
- Paper Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients:… DOI 10.1016/j.ejca.2021.08.002 ↗
- Paper Attenuated FOLFIRINOX in the salvage treatment of gemcitabine-refractory advanced pancreatic cancer: a phase II study. DOI 10.1186/s40880-018-0304-1 ↗
Dae Young Zang · 1 shared paper, 2021 · strength 0.11
- Paper Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients:… DOI 10.1016/j.ejca.2021.08.002 ↗
Se‐Il Go · 1 shared paper, 2021 · strength 0.11
- Paper Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients:… DOI 10.1016/j.ejca.2021.08.002 ↗
Woo Kyun Bae · 1 shared paper, 2021 · strength 0.11
- Paper Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients:… DOI 10.1016/j.ejca.2021.08.002 ↗
Jun Ho Ji · 1 shared paper, 2021 · strength 0.11
- Paper Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients:… DOI 10.1016/j.ejca.2021.08.002 ↗
O Kyu Noh · 1 shared paper, 2017 · strength 0.06
- Paper Diagnostic evaluation of simulation CT images for adjuvant radiotherapy in pancreatic adenocarcinoma. DOI 10.1259/bjr.20170225 ↗
Bohyun Kim · 1 shared paper, 2017 · strength 0.06
- Paper Diagnostic evaluation of simulation CT images for adjuvant radiotherapy in pancreatic adenocarcinoma. DOI 10.1259/bjr.20170225 ↗
Jaesung Heo · 1 shared paper, 2017 · strength 0.06
- Paper Diagnostic evaluation of simulation CT images for adjuvant radiotherapy in pancreatic adenocarcinoma. DOI 10.1259/bjr.20170225 ↗
Mison Chun · 1 shared paper, 2017 · strength 0.06
- Paper Diagnostic evaluation of simulation CT images for adjuvant radiotherapy in pancreatic adenocarcinoma. DOI 10.1259/bjr.20170225 ↗
Min Jae Yang · 1 shared paper, 2017 · strength 0.06
- Paper Vascular enhancement pattern of mass in computed tomography may predict chemo-responsiveness in advanced pancreatic can… DOI 10.1016/j.pan.2016.10.008 ↗
Shin Il Kim · 1 shared paper, 2017 · strength 0.06
- Paper Vascular enhancement pattern of mass in computed tomography may predict chemo-responsiveness in advanced pancreatic can… DOI 10.1016/j.pan.2016.10.008 ↗
Jin‐Seok Park · 1 shared paper, 2017 · strength 0.06
- Paper Vascular enhancement pattern of mass in computed tomography may predict chemo-responsiveness in advanced pancreatic can… DOI 10.1016/j.pan.2016.10.008 ↗
Jin Hong Kim · 1 shared paper, 2017 · strength 0.06
- Paper Vascular enhancement pattern of mass in computed tomography may predict chemo-responsiveness in advanced pancreatic can… DOI 10.1016/j.pan.2016.10.008 ↗
Jong Ho Moon · 1 shared paper, 2017 · strength 0.06
- Paper Vascular enhancement pattern of mass in computed tomography may predict chemo-responsiveness in advanced pancreatic can… DOI 10.1016/j.pan.2016.10.008 ↗
Don Haeng Lee · 1 shared paper, 2017 · strength 0.06
- Paper Vascular enhancement pattern of mass in computed tomography may predict chemo-responsiveness in advanced pancreatic can… DOI 10.1016/j.pan.2016.10.008 ↗
Chang‐Il Kwon · 1 shared paper, 2017 · strength 0.06
- Paper Vascular enhancement pattern of mass in computed tomography may predict chemo-responsiveness in advanced pancreatic can… DOI 10.1016/j.pan.2016.10.008 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.